Problems and precautions / A question brief
What changes with pregnancy or plans for it?
Name pregnancy, breastfeeding, or plans for pregnancy in the conversation. The exact medicine matters.
Do the labels all say the same thing?
No. The semaglutide (Ozempic) label checked in September 2026 says to stop the medicine two months or more ahead of a planned pregnancy.
The label for tirzepatide (Zepbound) checked in September 2026 instead says to stop it when pregnancy is known.
These sentences describe the labels. Ask the person prescribing your medicine what they mean for your own treatment and timing.
What if it is a pharmacy-made medicine?
Preparing a medicine to order is called compounding.
FDA means the Food and Drug Administration; it does not approve these pharmacy-made medicines, as of September 2026.
As checked in September 2026, pharmacy-made or unapproved products do not have pregnancy and breastfeeding information reviewed by FDA as part of approval. This does not mean no information exists. It means you do not have the same FDA-reviewed label as an approved medicine.
Missing FDA review does not mean the product is safe in pregnancy or while breastfeeding. Ask how that uncertainty affects your care.
What can I bring to that discussion?
- The name and form of every medicine I take
- Whether I am pregnant, breastfeeding, or planning pregnancy
- The timing I want to discuss
- The person who coordinates my care
Write down the answers about the specific product. Do not use a general peptide page to change a personal prescription.